CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sumitomo Chemical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sumitomo Chemical Co Ltd
Tokyo Sumitomo Twin Bldg. East Kan
2-27-1, Shinkawa
Phone: +81 352010200p:+81 352010200 CHUO-KU, TKY  103-6020  Japan Ticker: 40054005
Business Summary
Sumitomo Chemical Co Ltd is a Japan-based company that operates the chemical business. The Company has five segments. Essential & Green Materials segment manufactures and sells synthetic resins, raw materials for synthetic fibers, industrial chemicals, methacrylate, processed synthetic resin products, aluminum and alumina and synthetic rubber. Advanced Medical Solutions segment handles process development and contract manufacturing for pharmaceuticals and others. Information and Communication Technology (ICT) & Mobility Solutions segment handles optical products, semiconductor process materials, compound semiconductor materials, touch sensor panels, chemical products, engineering plastics and battery materials. Agro & Life Solutions segment handles agricultural chemicals, fertilizers, agricultural materials, pest control insecticides and materials for tropical disease control. Sumitomo Pharma segment handles small molecule pharmaceuticals. The Company also provides other businesses.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20253/31/2025Yes----

Industries
SIC Code Description
2869 Industrial organic chemicals, not elsewhere classified
2819 Industrial inorganic chemicals, not elsewhere classified
2879 Pesticides and agricultural chemicals, not elsewhere classified
2834 Pharmaceutical preparations
4225 General warehousing and storage
2865 Cyclic organic crudes and intermediates, and organic dyes and pigments
2822 Synthetic rubber (vulcanizable elastomers)
4911 Electric services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Representative Director KeiichiIwata 67 4/1/2025 4/1/2010
President, Executive President, Representative Director NobuakiMito 64 6/1/2025 4/1/2015
Executive Vice President, Director HiroshiNiinuma 67 4/1/2022 4/1/2010
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
SUMIKA POLYMER COMPOUNDS (EUROPE) LTD 28 NEW LANE HAVANT UK
SUMIKA POLYMER COMPOUNDS (UK) LTD 28 NEW LANE HAVANT UK
Sumitomo Pharma Switzerland GmbH AESCHENGRABEN 27,4051 BASEL SWITZERLAND
24 additional Subsidiary records available in full report.

Business Names
Business Name
4005
Altavant Sciences GmbH
Boston Biomedical Inc.
73 additional Business Names available in full report.

General Information
Number of Employees: 29,279 (As of 3/31/2025)
Outstanding Shares: 1,637,397,366 (As of 7/18/2025)
Shareholders: 235,014
Stock Exchange: TYO
Fax Number: +81 352010430


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 2, 2025